Andlauer Healthcare Group (TSE:AND – Get Free Report) had its target price upped by research analysts at Royal Bank of Canada from C$41.00 to C$42.00 in a report released on Friday, BayStreet.CA reports. The brokerage presently has a “sector perform” rating on the stock. Royal Bank of Canada’s target price points to a potential upside of 0.38% from the stock’s previous close.
Several other research firms have also recently commented on AND. Eight Capital lowered their target price on shares of Andlauer Healthcare Group from C$58.00 to C$51.00 and set a “buy” rating on the stock in a research note on Friday. Stifel Nicolaus lowered their target price on shares of Andlauer Healthcare Group from C$55.00 to C$52.00 and set a “buy” rating on the stock in a research note on Monday, May 6th. Scotiabank reduced their price objective on shares of Andlauer Healthcare Group from C$46.00 to C$45.00 and set a “sector perform” rating for the company in a research report on Friday. CIBC reduced their price objective on shares of Andlauer Healthcare Group from C$52.00 to C$50.00 and set an “outperform” rating for the company in a research report on Monday, May 6th. Finally, TD Securities reduced their price objective on shares of Andlauer Healthcare Group from C$54.00 to C$52.00 and set a “buy” rating for the company in a research report on Monday, May 6th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of C$48.57.
Check Out Our Latest Analysis on AND
Andlauer Healthcare Group Stock Performance
Andlauer Healthcare Group (TSE:AND – Get Free Report) last released its earnings results on Thursday, May 2nd. The company reported C$0.35 EPS for the quarter, missing the consensus estimate of C$0.53 by C($0.18). The company had revenue of C$161.14 million for the quarter, compared to analyst estimates of C$168.50 million. Andlauer Healthcare Group had a net margin of 10.02% and a return on equity of 13.82%. As a group, equities analysts forecast that Andlauer Healthcare Group will post 1.6396243 earnings per share for the current year.
Insiders Place Their Bets
In other Andlauer Healthcare Group news, Director Ronald Martin Skelton sold 1,500 shares of the firm’s stock in a transaction dated Wednesday, May 8th. The shares were sold at an average price of C$40.87, for a total value of C$61,309.95. Corporate insiders own 1.43% of the company’s stock.
Andlauer Healthcare Group Company Profile
Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.
Read More
- Five stocks we like better than Andlauer Healthcare Group
- Profitably Trade Stocks at 52-Week Highs
- Should You Invest in Bitcoin? Pros and Cons
- How to Use the MarketBeat Stock Screener
- Amazon Stock is Primed to Rebound Strongly After AI Bubble Bursts
- How to Invest in Small Cap StocksĀ
- Shell Stock: Oil & Gas Giant Committed to Buybacks and Dividends
Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.